Biologic Scaffold Prostheses to Enhance Meniscus Repair
Biologic Scaffold Prostheses to Enhance Meniscus Repair
批准号:
8839270
负责人:
Joe Brice Weinberg
金额:
$0.0万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2009
资助国家:
美国
项目状态:
已结题
起止时间:
2009-07-01 至 2013-06-30
关键词:
3-DimensionalAgingBiological MarkersBiomechanicsCanis familiarisCaringCartilageCategoriesCell Differentiation processCellsDegenerative polyarthritisDevelopmentDevicesDiagnosisDiseaseFiberFibrinGait abnormalityGelGoalsGrowthGrowth FactorHistologicHydrogelsImplantIn VitroInflammationInflammation MediatorsInjuryInterleukin-1JointsKneeKnee jointLeftMechanical StressMechanicsMedial meniscus structureMediator of activation proteinMedicalMeniscus structure of jointMetabolismMethodsMilitary PersonnelMissionMoldsMorbidity - disease rateMorphologyMusculoskeletal SystemNitric OxideObesityOrthopedicsOsteoarthrosis DeformansPainPathologicPathologyPatient CarePerformancePhenotypePhysiologicalPlayProductionPropertyProstaglandinsProsthesisPublic HealthRecoveryResectedRheumatoid ArthritisRoleSecondary toSerumServicesSiteStructureSynovial FluidSystemTechnologyTestingTimeTissue EngineeringTissuesTransforming Growth Factor betaTraumaUnited StatesVariantVeteransWorkabstractingarticular cartilagebasebonebone morphogenetic protein 2bone morphogenetic protein 6cytokinedesigndesign and constructiondisabilityimplantationin vivojoint functionjoint loadingminiaturizenovelosteogenicpreventrepairedresearch studyresponsescaffoldstem cell technologytibiatransmission process
中文摘要
摘要
英文摘要
Abstract
Menisci play critical roles in stabilization and load transmission in the knee joint. Meniscal damage or loss
often results in progressive osteoarthritic degeneration of the articular cartilage and other joint tissues,
leading to significant pain and disability. We need better methods to repair or replace damaged menisci.
However, most tissue engineering approaches for meniscal replacement require significant culture time for
the newly formed tissue to develop functional properties that could withstand joint loading. We have
demonstrated the usefulness of three dimensional (3-D) woven scaffolds for tissue engineering purposes.
These scaffolds provide physiologic mechanical properties prior to implantation. We have also shown that
mechanical stress and cytokines alter the metabolism of menisci and inhibit repair of meniscal injury. The
overall goal of our study is to develop a new 3-D composite scaffold for use in the functional tissue
engineering of the meniscus. A special advantage of 3-D weaving is that constructs can be designed and
built with predetermined control of site-dependent variations in mechanical properties. Also, certain
growth factors that may enhance meniscus-bone molding and annealing can be incorporated into the
matrix. We will develop the device and also determine effects of soluble mediators such as cytokines,
nitric oxide (NO), and prostaglandins (PG) on development, integrity, and function of the prostheses. We
will accomplish 4 aims. Aim 1. Design and construct 3-D woven composite scaffolds for use in the
functional tissue engineering of the knee meniscus. We will develop a composite scaffold that promotes
meniscal fibrochondrocyte development and tissue organization, while effectively replicating the structural
and functional mechanical properties of a natural meniscus. Aim 2: Incorporate bioactive factors into the
3-D matrix that will allow fibrochondrocyte differentiation and attachment to bone. We will incorporate
growth factors into the materials used in Aim 1 to construct the 3-D woven composite scaffolds. Aim 3:
Perform mechanical testing of the composite scaffolds to assess their potential in vitro functionality.
Tension, compression, and shear testing will be used to evaluate the critical biomechanical parameters of
the developed scaffolds and resulting neomeniscus. We will assess the importance of certain cytokines,
growth factors, and other natural mediators such as NO and PG on the development and biomechanical
properties of the meniscus prostheses. Aim 4: Test the ability of the meniscus scaffold prosthesis to
attach to bone and function in vivo. We will place the in vitro-generated meniscus prostheses into sites of
fresh-ly resected medial menisci in dogs and leave the prostheses in place for up to 12 weeks, after which
we will evaluate their function and their effects on development of pathology in the joint. Our work will have
a direct effect on veterans with meniscal injuries, facilitating a more rapid recovery and reducing long term
morbidity. Also, for active-duty military personnel, it may result in more rapid return to active duty.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Nitric Oxide and Malaria
-
批准号:8331804
-
项目类别:
-
资助金额:$19.92万
-
财政年份:2012
-
负责人:Joe Brice Weinberg
-
依托单位:
Biologic Scaffold Prostheses to Enhance Meniscus Repair
-
批准号:7888242
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2009
-
负责人:Joe Brice Weinberg
-
依托单位:
Biologic scaffold prostheses to enhance meniscus repair
-
批准号:7749325
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2009
-
负责人:Joe Brice Weinberg
-
依托单位:
Biologic Scaffold Prostheses to Enhance Meniscus Repair
-
批准号:8838088
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2009
-
负责人:Joe Brice Weinberg
-
依托单位:
Inducible NOS as a Treatment Target in CLL
-
批准号:6633986
-
项目类别:
-
资助金额:$26.56万
-
财政年份:2001
-
负责人:Joe Brice Weinberg
-
依托单位:
Inducible NOS as a Treatment Target in CLL
-
批准号:6514971
-
项目类别:
-
资助金额:$26.56万
-
财政年份:2001
-
负责人:Joe Brice Weinberg
-
依托单位:
Inducible NOS as a Treatment Target in CLL
-
批准号:6757870
-
项目类别:
-
资助金额:$26.56万
-
财政年份:2001
-
负责人:Joe Brice Weinberg
-
依托单位:
Inducible NOS as a Treatment Target in CLL
-
批准号:6886702
-
项目类别:
-
资助金额:$26.56万
-
财政年份:2001
-
负责人:Joe Brice Weinberg
-
依托单位:
Inducible NOS as a Treatment Target in CLL
-
批准号:6320364
-
项目类别:
-
资助金额:$26.56万
-
财政年份:2001
-
负责人:Joe Brice Weinberg
-
依托单位:
NITRIC OXIDE AND RHEUMATOID ARTHRITIS
-
批准号:6348928
-
项目类别:
-
资助金额:$21.36万
-
财政年份:2000
-
负责人:Joe Brice Weinberg
-
依托单位:
NITRIC OXIDE AND RHEUMATOID ARTHRITIS
-
批准号:6201511
-
项目类别:
-
资助金额:$21.36万
-
财政年份:1999
-
负责人:Joe Brice Weinberg
-
依托单位:
NITRIC OXIDE AND RHEUMATOID ARTHRITIS
-
批准号:6100451
-
项目类别:
-
资助金额:$21.36万
-
财政年份:1998
-
负责人:Joe Brice Weinberg
-
依托单位:
NITRIC OXIDE AND SEVERE MALARIA
-
批准号:2887552
-
项目类别:
-
资助金额:$48.39万
-
财政年份:1997
-
负责人:Joe Brice Weinberg
-
依托单位:
NITRIC OXIDE AND SEVERE MALARIA
-
批准号:2556315
-
项目类别:
-
资助金额:$48.12万
-
财政年份:1997
-
负责人:Joe Brice Weinberg
-
依托单位:
Arginine, Nitric Oxide, and Severe Malaria
-
批准号:8307935
-
项目类别:
-
资助金额:$56.94万
-
财政年份:1997
-
负责人:Joe Brice Weinberg
-
依托单位:
Arginine, Nitric Oxide, and Severe Malaria
-
批准号:7932280
-
项目类别:
-
资助金额:$58.01万
-
财政年份:1997
-
负责人:Joe Brice Weinberg
-
依托单位:
NITRIC OXIDE AND RHEUMATOID ARTHRITIS
-
批准号:6235730
-
项目类别:
-
资助金额:$20.99万
-
财政年份:1997
-
负责人:Joe Brice Weinberg
-
依托单位:
Arginine, Nitric Oxide, and Severe Malaria
-
批准号:7528065
-
项目类别:
-
资助金额:$60.39万
-
财政年份:1997
-
负责人:Joe Brice Weinberg
-
依托单位:
Nitric Oxide and Severe Malaria
-
批准号:6749010
-
项目类别:
-
资助金额:$51.42万
-
财政年份:1997
-
负责人:Joe Brice Weinberg
-
依托单位:
Nitric Oxide and Severe Malaria
-
批准号:6619982
-
项目类别:
-
资助金额:$38.9万
-
财政年份:1997
-
负责人:Joe Brice Weinberg
-
依托单位:
海外基金